Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Diseases, Interstitial | 3 | 2022 | 110 | 0.400 |
Why?
|
| Sjogren's Syndrome | 2 | 2022 | 18 | 0.320 |
Why?
|
| Postmortem Changes | 1 | 2006 | 15 | 0.280 |
Why?
|
| Propylamines | 1 | 2006 | 22 | 0.280 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 2006 | 20 | 0.280 |
Why?
|
| Asthma | 2 | 2022 | 345 | 0.250 |
Why?
|
| Parotitis | 1 | 2022 | 7 | 0.220 |
Why?
|
| Lung | 4 | 2022 | 849 | 0.220 |
Why?
|
| Granuloma | 1 | 2020 | 21 | 0.190 |
Why?
|
| Lung Diseases | 1 | 2020 | 175 | 0.170 |
Why?
|
| Vasculitis | 2 | 2020 | 33 | 0.160 |
Why?
|
| Cranial Sutures | 1 | 2016 | 7 | 0.140 |
Why?
|
| Alexander Disease | 1 | 2015 | 1 | 0.140 |
Why?
|
| Caveolin 1 | 2 | 2014 | 59 | 0.130 |
Why?
|
| Fractures, Bone | 1 | 2016 | 132 | 0.130 |
Why?
|
| Infusion Pumps | 1 | 2014 | 39 | 0.120 |
Why?
|
| Bleomycin | 1 | 2014 | 67 | 0.120 |
Why?
|
| Child Abuse | 1 | 2016 | 186 | 0.120 |
Why?
|
| Monocytes | 2 | 2012 | 210 | 0.120 |
Why?
|
| Cryopreservation | 1 | 2014 | 103 | 0.120 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2014 | 82 | 0.120 |
Why?
|
| Amino Acyl-tRNA Synthetases | 1 | 2013 | 2 | 0.120 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2013 | 35 | 0.110 |
Why?
|
| Astrocytes | 1 | 2015 | 270 | 0.110 |
Why?
|
| Capillaries | 1 | 2013 | 105 | 0.110 |
Why?
|
| Bronchi | 1 | 2012 | 59 | 0.110 |
Why?
|
| Imidazoles | 1 | 2013 | 175 | 0.110 |
Why?
|
| Cellular Senescence | 1 | 2013 | 112 | 0.110 |
Why?
|
| Drug Delivery Systems | 1 | 2014 | 236 | 0.100 |
Why?
|
| Piperazines | 1 | 2013 | 206 | 0.100 |
Why?
|
| Tenosynovitis | 1 | 2011 | 2 | 0.100 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2012 | 201 | 0.100 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2013 | 231 | 0.100 |
Why?
|
| Sarcoidosis, Pulmonary | 1 | 2011 | 17 | 0.100 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2012 | 102 | 0.100 |
Why?
|
| Bronchial Diseases | 1 | 2010 | 9 | 0.100 |
Why?
|
| Aorta | 1 | 2012 | 316 | 0.090 |
Why?
|
| Autoantibodies | 1 | 2013 | 434 | 0.090 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2010 | 27 | 0.090 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2010 | 93 | 0.090 |
Why?
|
| Lymphoma | 1 | 2010 | 116 | 0.090 |
Why?
|
| Epithelial Cells | 1 | 2012 | 431 | 0.090 |
Why?
|
| Scleroderma, Systemic | 1 | 2014 | 446 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2016 | 2323 | 0.090 |
Why?
|
| Dinoprostone | 1 | 2010 | 110 | 0.090 |
Why?
|
| Cell Proliferation | 2 | 2013 | 1173 | 0.090 |
Why?
|
| Lipoproteins, LDL | 1 | 2012 | 343 | 0.090 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2010 | 144 | 0.090 |
Why?
|
| Sphingolipids | 1 | 2012 | 337 | 0.080 |
Why?
|
| Humans | 18 | 2022 | 68525 | 0.080 |
Why?
|
| Herpes Simplex | 1 | 2008 | 35 | 0.080 |
Why?
|
| Liver Failure, Acute | 1 | 2008 | 49 | 0.080 |
Why?
|
| Receptors, Leukotriene | 1 | 2007 | 8 | 0.080 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2006 | 5 | 0.070 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2006 | 9 | 0.070 |
Why?
|
| Fatal Outcome | 3 | 2016 | 164 | 0.070 |
Why?
|
| Muscle Contraction | 1 | 2007 | 210 | 0.070 |
Why?
|
| Atomoxetine Hydrochloride | 1 | 2006 | 14 | 0.070 |
Why?
|
| Chromatography, Gas | 1 | 2006 | 31 | 0.070 |
Why?
|
| Protein Kinase C | 1 | 2007 | 270 | 0.070 |
Why?
|
| Influenza, Human | 1 | 2006 | 79 | 0.070 |
Why?
|
| Tissue Distribution | 1 | 2006 | 282 | 0.070 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2012 | 756 | 0.070 |
Why?
|
| Norepinephrine | 1 | 2006 | 276 | 0.070 |
Why?
|
| Drug Interactions | 1 | 2006 | 289 | 0.070 |
Why?
|
| Drug Overdose | 1 | 2006 | 67 | 0.060 |
Why?
|
| Child, Preschool | 3 | 2022 | 3185 | 0.060 |
Why?
|
| Suicide | 1 | 2006 | 115 | 0.060 |
Why?
|
| Molecular Structure | 1 | 2006 | 397 | 0.060 |
Why?
|
| Lung Neoplasms | 1 | 2013 | 1172 | 0.060 |
Why?
|
| Mediastinal Diseases | 1 | 2004 | 15 | 0.060 |
Why?
|
| Aspergillosis | 1 | 2004 | 20 | 0.060 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2006 | 189 | 0.060 |
Why?
|
| Female | 8 | 2022 | 38015 | 0.060 |
Why?
|
| Child | 2 | 2022 | 6400 | 0.060 |
Why?
|
| Rare Diseases | 1 | 2022 | 41 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2007 | 617 | 0.050 |
Why?
|
| Male | 7 | 2022 | 37281 | 0.050 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2014 | 144 | 0.050 |
Why?
|
| Alveolitis, Extrinsic Allergic | 1 | 2020 | 6 | 0.050 |
Why?
|
| Mycobacterium Infections | 1 | 2020 | 13 | 0.050 |
Why?
|
| Mycoses | 1 | 2020 | 60 | 0.050 |
Why?
|
| Sarcoidosis | 1 | 2020 | 77 | 0.050 |
Why?
|
| Mice | 4 | 2014 | 8472 | 0.040 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 1999 | 37 | 0.040 |
Why?
|
| Myeloproliferative Disorders | 1 | 1999 | 11 | 0.040 |
Why?
|
| Translocation, Genetic | 1 | 1999 | 74 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 1032 | 0.040 |
Why?
|
| Trachea | 2 | 2010 | 48 | 0.040 |
Why?
|
| Muscle, Smooth | 2 | 2010 | 117 | 0.040 |
Why?
|
| Animals | 5 | 2015 | 20877 | 0.040 |
Why?
|
| Diagnosis, Differential | 2 | 2016 | 1139 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2016 | 2453 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2015 | 2550 | 0.040 |
Why?
|
| Disease Progression | 2 | 2015 | 1037 | 0.030 |
Why?
|
| Neuroimmunomodulation | 1 | 2015 | 16 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2015 | 92 | 0.030 |
Why?
|
| Tissue Banks | 1 | 2014 | 13 | 0.030 |
Why?
|
| Adult | 3 | 2013 | 21375 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2014 | 62 | 0.030 |
Why?
|
| Microglia | 1 | 2015 | 143 | 0.030 |
Why?
|
| Cryoprotective Agents | 1 | 2014 | 31 | 0.030 |
Why?
|
| Spinal Cord | 1 | 2015 | 244 | 0.030 |
Why?
|
| Osmosis | 1 | 2014 | 38 | 0.030 |
Why?
|
| Protein Stability | 1 | 2014 | 89 | 0.030 |
Why?
|
| RNA Stability | 1 | 2014 | 55 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2016 | 333 | 0.030 |
Why?
|
| Pulmonary Alveoli | 1 | 2014 | 62 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2014 | 196 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 282 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2013 | 24 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2013 | 51 | 0.030 |
Why?
|
| Radiation, Ionizing | 1 | 2013 | 37 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2013 | 2688 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2013 | 97 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2010 | 1199 | 0.030 |
Why?
|
| Proteomics | 1 | 2014 | 246 | 0.030 |
Why?
|
| Hippocampus | 1 | 2015 | 471 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 498 | 0.030 |
Why?
|
| Weight Loss | 1 | 2014 | 319 | 0.030 |
Why?
|
| Cell Survival | 1 | 2014 | 901 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2013 | 648 | 0.020 |
Why?
|
| Antirheumatic Agents | 1 | 2011 | 58 | 0.020 |
Why?
|
| Biopsy | 1 | 2013 | 539 | 0.020 |
Why?
|
| Cytokines | 1 | 2015 | 866 | 0.020 |
Why?
|
| Methotrexate | 1 | 2011 | 91 | 0.020 |
Why?
|
| Salmeterol Xinafoate | 1 | 2010 | 3 | 0.020 |
Why?
|
| Pseudolymphoma | 1 | 2010 | 6 | 0.020 |
Why?
|
| Familial Primary Pulmonary Hypertension | 1 | 2010 | 25 | 0.020 |
Why?
|
| Albuterol | 1 | 2010 | 26 | 0.020 |
Why?
|
| Isoproterenol | 1 | 2010 | 163 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 2010 | 95 | 0.020 |
Why?
|
| Amyloidosis | 1 | 2010 | 48 | 0.020 |
Why?
|
| Bronchodilator Agents | 1 | 2010 | 43 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2010 | 254 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 200 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2013 | 7028 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2010 | 150 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2010 | 147 | 0.020 |
Why?
|
| Acute Disease | 1 | 2011 | 658 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2010 | 222 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 216 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2010 | 214 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2013 | 514 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2010 | 791 | 0.020 |
Why?
|
| Infant | 1 | 2015 | 2891 | 0.020 |
Why?
|
| Transfection | 1 | 2010 | 782 | 0.020 |
Why?
|
| Simplexvirus | 1 | 2008 | 26 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 1849 | 0.020 |
Why?
|
| Hypertension, Pulmonary | 1 | 2010 | 232 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2012 | 1692 | 0.020 |
Why?
|
| Leukotrienes | 1 | 2007 | 13 | 0.020 |
Why?
|
| Inhalation | 1 | 2007 | 11 | 0.020 |
Why?
|
| Phosphatidylinositols | 1 | 2007 | 40 | 0.020 |
Why?
|
| Biomarkers | 1 | 2013 | 1593 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 2790 | 0.020 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2007 | 48 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2007 | 101 | 0.020 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2006 | 52 | 0.020 |
Why?
|
| Apoptosis | 1 | 2013 | 1640 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2007 | 492 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2006 | 168 | 0.020 |
Why?
|
| Heart Arrest | 1 | 2006 | 113 | 0.020 |
Why?
|
| Prognosis | 1 | 2010 | 2093 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2010 | 2673 | 0.020 |
Why?
|
| Mediastinal Neoplasms | 1 | 2004 | 27 | 0.020 |
Why?
|
| Thoracotomy | 1 | 2004 | 25 | 0.020 |
Why?
|
| Calcium | 1 | 2007 | 929 | 0.010 |
Why?
|
| Lung Transplantation | 1 | 2004 | 88 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 1851 | 0.010 |
Why?
|
| Time Factors | 1 | 2010 | 4655 | 0.010 |
Why?
|
| Chromosome Painting | 1 | 1999 | 3 | 0.010 |
Why?
|
| Acute-Phase Reaction | 1 | 1999 | 10 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 1999 | 9 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 1999 | 15 | 0.010 |
Why?
|
| Middle Aged | 2 | 2011 | 21119 | 0.010 |
Why?
|
| Blotting, Western | 1 | 1999 | 954 | 0.010 |
Why?
|